Codes / ICD10CM / T45.0X3A

T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by antiallergic and antiemetic drugs, assault, initial encounter (ICD-10 code: T45.0X3A)

Summary

This condition involves harmful effects resulting from intentional exposure to antiallergic or antiemetic drugs due to assault. It reflects deliberate administration or forced ingestion of these medications, leading to poisoning or toxic reactions. The encounter is classified as initial, indicating the patient is receiving care for the acute event.

Causes

Poisoning occurs when antiallergic (e.g., antihistamines) or antiemetic (e.g., drugs to prevent nausea/vomiting) drugs are administered intentionally by another party, often as part of an assault. This may involve forced ingestion, injection, or other forms of exposure without the patient’s consent.

Risk Factors

  • Exposure to situations involving interpersonal violence or coercion.
  • Presence of antiallergic or antiemetic drugs in environments where assault may occur.
  • Lack of supervision or protective measures in vulnerable settings.

Symptoms

  • Drowsiness, confusion, or altered mental status.
  • Tachycardia, hypotension, or cardiac arrhythmias.
  • Respiratory depression, shallow breathing, or cyanosis.
  • Nausea, vomiting, or abdominal pain.
  • Seizures, coma, or other neurological impairment.

Diagnosis

Diagnosis relies on a detailed history of the assault, clinical presentation, and, if available, laboratory tests to identify the specific drug or its metabolites. Physical examination may reveal signs of trauma or forced exposure. Documentation should include details of the assault when available.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the toxic effects of the drugs. This may include airway support, cardiovascular monitoring, and administration of antidotes or supportive care. The assault should be reported to appropriate authorities as required.

Prognosis and Follow-Up

Prognosis depends on the dose and type of drug, timeliness of treatment, and overall patient health. Follow-up care may involve monitoring for delayed effects, addressing psychological impacts of the assault, and coordinating with social or legal services as needed.

Complications

  • Severe respiratory or cardiac compromise.
  • Neurological damage (e.g., seizures, coma).
  • Long-term psychological trauma related to the assault.
  • Organ damage from drug toxicity.

Lifestyle & Prevention

Prevention involves avoiding high-risk situations and ensuring safe environments. For healthcare providers, documenting the circumstances of exposure and assault is critical for legal and clinical follow-up.

When to Seek Professional Help

Seek immediate medical attention if exposure to antiallergic or antiemetic drugs occurs under suspicious or forced circumstances. Signs of poisoning, such as altered consciousness, respiratory distress, or severe symptoms, require urgent evaluation.

Tips for Medical Coders

Code T45.0X3A is used for initial encounters of poisoning by antiallergic or antiemetic drugs due to assault. Documentation should clearly indicate the assault as the cause and specify the initial encounter. Ensure the code aligns with the clinical scenario and avoid using this code for accidental or self-harm cases.

Book a walkthrough

T45.0X3A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.